Ursprung des Netzwerks ersten Grades von Paul G. Cerjan
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
StormBio, Inc.
StormBio, Inc. Drugstore ChainsRetail Trade StormBio, Inc. provides biopharmaceutical services. It develops therapeutics for treating highly pathogenic influenza. The company is headquartered in Westfield, NJ.
3
| Private Company | Drugstore Chains | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Paul G. Cerjan
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
WBB Securities LLC
WBB Securities LLC Investment Banks/BrokersFinance Founded in 2001 by Stephen Brozak, WBB Securities LLC is an SEC-registered broker/dealer headquartered in San Diego, California. Their services include order execution, back office administration and research. The firm follows the biotechnology, medical devices and healthcare industries. WBB Securities is a member of FINRA, the NASD and the SIPC. | Investment Banks/Brokers | Founder | |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
180 LIFE SCIENCES CORP. | Pharmaceuticals: Major | Founder | |
180 Life Corp.
180 Life Corp. Pharmaceuticals: MajorHealth Technology 180 Life Sciences Corp. engages in manufacture of pharmaceutical products. The company is headquartered in New York. | Pharmaceuticals: Major | Chairman | |
Lupus Research Alliance, Inc.
Lupus Research Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services Lupus Research Alliance, Inc. provides research and development for the treatment of lupus disease. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
University of Oxford | College/University | Corporate Officer/Principal | |
Katexco Pharmaceuticals Corp.
Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Katexco Pharmaceuticals Corp. operates as medical marijuana company that engages in the development of orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases. The company was founded by Jonathan Rothbard, Lawrence Steinman and Marc Feldmann and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Founder | |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
ReFormation Pharmaceuticals Corp.
ReFormation Pharmaceuticals Corp. Agricultural Commodities/MillingProcess Industries ReFormation Pharmaceuticals Corp. operates as a medical marijuana pharmaceutical company. It focuses on repairing vital organs by combining cannabinoids and an endogenous trigger of repair. The company was founded by Marc Feldmann and Jagdeep Nanchahal and is headquartered in Toronto, Canada. | Agricultural Commodities/Milling | Founder | |
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Founder | |
Kennedy Institute of Rheumatology
Kennedy Institute of Rheumatology Pharmaceuticals: MajorHealth Technology Part of University of Oxford, Kennedy Institute of Rheumatology is a research facility that focuses on studying host-microbe crosstalk in health and disease, with a particular emphasis on inflammatory bowel disease, colorectal cancer, and inflammatory arthritis. The Kennedy Institute of Rheumatology is based in Headington, UK. The institute employs advanced microscopy methods and cutting-edge technology to generate a wide variety of data, which is made available to researchers through the Research Informatics team. The facility aims to future-proof excellence for Bioimaging within Oxford, keeping it competitive with international research. | Pharmaceuticals: Major | Corporate Officer/Principal | |
HEMOGENYX PHARMACEUTICALS PLC | Biotechnology | Chairman | |
Nuon Therapeutics, Inc.
Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Founder | |
Drew University | College/University | Doctorate Degree | |
Enosi Life Sciences Corp.
Enosi Life Sciences Corp. BiotechnologyHealth Technology Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021. | Biotechnology | Founder |
Statistik
International
Vereinigte Staaten | 10 |
Vereinigtes Königreich | 4 |
Kanada | 4 |
Belgien | 2 |
Australien | 2 |
Sektoral
Health Technology | 9 |
Consumer Services | 5 |
Finance | 3 |
Commercial Services | 3 |
Process Industries | 2 |
Operativ
Chairman | 7 |
Founder | 7 |
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Marc Feldmann | 15 |
Steve Brozak | 4 |
James Larrick | 1 |
- Börse
- Insiders
- Paul G. Cerjan
- Unternehmensverbindungen